CAPTRUST Financial Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,344
Closed -$26K 3636
2022
Q2
$26K Buy
1,344
+1,286
+2,217% +$24.9K ﹤0.01% 3226
2022
Q1
$2K Buy
+58
New +$2K ﹤0.01% 4533